MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 234 filers reported holding MYRIAD GENETICS INC in Q1 2016. The put-call ratio across all filers is 2.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $204,000 | +96.2% | 4,425 | +59.2% | 0.19% | +101.0% |
| Q2 2018 | $104,000 | -29.7% | 2,780 | -29.6% | 0.10% | +159.5% |
| Q1 2016 | $148,000 | -54.5% | 3,950 | -53.1% | 0.04% | -51.9% |
| Q3 2014 | $325,000 | -0.9% | 8,425 | 0.0% | 0.08% | +2.7% |
| Q2 2014 | $328,000 | +13.9% | 8,425 | 0.0% | 0.08% | +8.7% |
| Q1 2014 | $288,000 | -86.2% | 8,425 | -90.5% | 0.07% | -87.9% |
| Q3 2013 | $2,080,000 | -99.9% | 88,520 | -0.6% | 0.57% | -18.6% |
| Q2 2013 | $2,392,102,000 | – | 89,025 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |